News
-
-
PRESS RELEASE
Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease. Acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis and a promising pipeline in immunology -
-
-
-
-
-
PRESS RELEASE
Sparta Capital Announces Filing of Interim Financial Statements
Sparta Group files interim financial statements for the three-month period ended March 31, 2024. Alberta Securities Commission issues a cease trade order against the company. Sparta operates in environment, health, and transportation sectors -
PRESS RELEASE
KKR Increases Offer Price for Public Purchase Offer for DATAGROUP Shares conditional upon Final Acceptance Level, Best and Final Offer for DATAGROUP Shares Expires on 6 June 2025
KKR increases offer price for public purchase offer for DATAGROUP shares conditional upon final acceptance level. Best and final offer expires on 6 June 2025 -